These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9782570)

  • 21. New insights into uremic toxicity.
    Raff AC; Meyer TW; Hostetter TH
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):560-5. PubMed ID: 18941347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma amino acid profile and L-arginine uptake in red blood cells from malnourished uremic patients.
    Reis PF; da Silva CD; Brunini TM; Moss MB; Siqueira MA; Santos SF; Roberts NB; Ellory JC; Mann GE; Mendes-Ribeiro AC
    J Ren Nutr; 2006 Oct; 16(4):325-31. PubMed ID: 17046616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbamoylation abrogates the antioxidant potential of hydrogen sulfide.
    Praschberger M; Hermann M; Laggner C; Jirovetz L; Exner M; Kapiotis S; Gmeiner BM; Laggner H
    Biochimie; 2013 Nov; 95(11):2069-75. PubMed ID: 23896375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hemodialysis on protein synthesis.
    Löfberg E; Essén P; McNurlan M; Wernerman J; Garlick P; Anderstam B; Bergström J; Alvestrand A
    Clin Nephrol; 2000 Oct; 54(4):284-94. PubMed ID: 11076104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
    Stefanović V; Antić S
    Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity?
    Vanholder R; Van Laecke S; Glorieux G
    J Nephrol; 2008; 21(2):146-60. PubMed ID: 18446708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscle growth and plasma concentrations of amino acids, insulin-like growth factor-I, and insulin in growing pigs fed reduced-protein diets.
    Guay F; Trottier NL
    J Anim Sci; 2006 Nov; 84(11):3010-9. PubMed ID: 17032795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Retention of medium sized molecules in uremic serum].
    Dall'aglio P; Buzio C; Cambi V; Arisi L; Migone L
    Proc Eur Dial Transplant Assoc; 1972; 9():409-16. PubMed ID: 4668919
    [No Abstract]   [Full Text] [Related]  

  • 29. Carbamoylated Nail Proteins as Assessed by Near-Infrared Analysis are Associated with Load of Uremic Toxins and Mortality in Hemodialysis Patients.
    Bruyne S; Himpe J; Delanghe SE; Glorieux G; Biesen WV; Buyzere ML; Speeckaert MM; Delanghe JR
    Toxins (Basel); 2020 Jan; 12(2):. PubMed ID: 31991867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and metabolic consequences of uremic toxicity].
    Rutkowski P
    Przegl Lek; 2006; 63(4):209-17. PubMed ID: 17080744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracorporeal strategies for the removal of middle molecules.
    Winchester JF; Audia PF
    Semin Dial; 2006; 19(2):110-4. PubMed ID: 16551287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Aspects of the on-line hemodiafiltration with regeneration and reinfusion of the ultrafiltrate (HFR): multicenter study].
    De Simone W; De Simone M; De Simone A; Iannaccone S; Manganelli R; Zito B; Guastaferro P; Apperti V; Paglionico C; Salvati G; Veniero P; Ferro F; Tedesco V
    G Ital Nefrol; 2004; 21 Suppl 30():S161-7. PubMed ID: 15750977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Problems and solutions for artificial kidney.
    Vanholder R
    Technol Health Care; 2000; 8(6):373-9. PubMed ID: 11258583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Carbamylation of proteins--mechanism, causes and consequences].
    Pieniążek A; Gwoździński K
    Postepy Hig Med Dosw (Online); 2016 May; 70():514-21. PubMed ID: 27180968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients.
    Bammens B; Evenepoel P; Verbeke K; Vanrenterghem Y
    Am J Kidney Dis; 2005 Sep; 46(3):512-9. PubMed ID: 16129214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Uremic toxins].
    Vanholder R
    Nephrologie; 2003; 24(7):373-6. PubMed ID: 14650749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicity of middle molecules: clinical evaluation using a selective filtration artificial kidney.
    Jörstad S; Smeby LC; Wideröe TE
    Artif Organs; 1981; 4 Suppl():98-103. PubMed ID: 7295103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodialysis of amino acids: basic studies in vitro.
    Riley V
    Nutr Cancer; 1981; 2(3):153-64. PubMed ID: 7346781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Depurative efficiency of intermediate and large molecules with different hemodialysis modalities].
    Maduell F
    Nefrologia; 2005; 25 Suppl 2():15-8. PubMed ID: 16050396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.